1. Market Research
  2. > Healthcare Market Trends
  3. > 2012 China New Medical Reform Policy Specific Analysis and the Influence on Medical Industry

The report is concentrated on the implementation of China New Medical Reform Policy and its influence on China medicine industry. The report analyzes the forthcoming National Essential Medicine List 2012 and conducts a statistics work on provinces added list. Besides, it also had a specific analysis on marketing channel of China medicine enterprises under New Medical Reform Policy. Generally, the report can provide advantageous reference for insiders and help you understand comprehensively China's current health reform process.

Table Of Contents

2012 China New Medical Reform Policy Specific Analysis and the Influence on Medical Industry
1. China New Medical Reform Policy Specific Analysis
1.1 Medical Reform History
1.1.1 Reasons of the Past Fail Cases
1.1.2 Basic Medical and Health System Mode of New Medical Reform Policy
1.1.3 Phasic Results of Three-year of Medical and Health Reform
1.2 Primary Care and Public Health Solve “Treatment Difficulty”
1.2.1 Reasons of “Treatment Difficulty”
1.2.2 Measures to Solve “Treatment Difficulty”
1.3 Medical Insurance, Basic Medicines, and Public Hospitals Reform Solve “Treatment Expensiveness”
1.3.1 Reasons of “Treatment Expensiveness”
1.3.2 Measures to Solve “Treatment Expensiveness”
1.4 New Medical Reform Policy Influence on Medical Enterprises
1.4.1 Opportunities and Challenges Brought by Medical Reform to Medical Enterprises
1.4.2 Influence of Medical Reform on Foreign Investment and Joint Ventures' Market Share
1.4.3 Organization of Medical and Health Reform in 2012
1.4.4 New Medical Reform Policy Shows Clearly the Future Direction of the Medical Reform
1.5 Influence of Medical Reform on Foreign Owned, Joint Ventures and China State-owned Enterprises
1.5.1 Influence on Foreign Owned Enterprises
1.5.2 Influence on Joint Ventures
1.5.3 Influence on China State-owned Enterprises
1.6 Strategy Analysis of Joint Ventures Coping with New Medical Reform Policy
1.6.1 Attach Importance to the Research and Development of Chinese Medicine and Patent Medicines
1.6.2 Pay Attention to the Medicine Needs of the Rural and Community
1.6.3 Adjust Strategy to Adapt to the Flat Channel
1.7 Industrial Pattern of Medicine Enterprises
1.7.1 Current Industrial Merger and Acquisition
1.7.2 Industry Concentration Ratio Planning during the “Twelfth Five-Year” Period
1.8 Forecast and Influence of Drug Code Adjustment in the Future
1.8.1 Comprehensive Check of the Drug Approval Number after the Implementation of New Medical Reform Policy
1.8.2 Drug Registration Approval Data Interpretation, 2008-2011
1.8.3 The “Twelfth Five-Year” Plan Required to Further Give Full Play to the Role of Drug Regulation

2. Medicine Marketing Channel Change under New Medical Reform
2.1 Marketing Channel of Medicine Enterprise
2.1.1 Main Marketing Channel of Different Medicine Categories
2.1.2 Original Marketing Channel
2.1.3 Development Trend of Marketing Channel
2.2 Influence of New Medical Reform Policy on Medicine Marketing
2.2.1 Expansion of Market Capacity and Surge of Generic Medicine Market
2.2.2 Change of Terminal Market and Rise of the Third Terminal
2.2.3 Much More Professional Marketing Mode
2.3 Influence of New Medical Reform Policy on Medicine Enterprises' Marketing Channel
2.3.1 Influence on Foreign Owned Enterprises
2.3.2 Influence on Joint Ventures
2.2.3 Influence on China Domestic Enterprises
2.4 Joint Ventures' Marketing Strategy under New Medical Reform
2.4.1 In Accordance With Polarization of Medicine Market
2.4.2 Enhance Marketing Activity with the Help of Commercial Channels
2.4.3 Improve the Quality of Employees via Professional Training
2.4.4 Organic Combination of Academic and public welfare

3. The Latest National Essential Medicine List and the Provinces Added List
3.1 Interpretation of New Version of the National Essential Medicine List
3.1.1 The Leadership of the Ministry of Health's Interpretation of New Version of the National Essential Medicine List
3.1.2 Interpretation of Informal Version of National Essential Medicine List
3.2 Provinces Added List

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016-2020 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2016-2020 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 28 500
  • Industry report
  • May 2016
  • by Venture Planning Group

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...

2016-2020 Global Clinical Chemistry and Immunodiagnostic Markets: Reagent and Instrument Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US

2016-2020 Global Clinical Chemistry and Immunodiagnostic Markets: Reagent and Instrument Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US

  • $ 23 500
  • Industry report
  • March 2016
  • by Venture Planning Group

Complete report $37,500.  DataPack (test volumes, sales forecasts, supplier shares) $23,500. VPGMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities ...

2016-2020  New Frontiers in the Global Clinical Chemistry and Immunodiagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

2016-2020 New Frontiers in the Global Clinical Chemistry and Immunodiagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 23 500
  • Industry report
  • March 2016
  • by Venture Planning Group

Complete report $37,500.  DataPack (test volumes, sales forecasts, supplier shares) $23,500. VPGMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging ...


ref:plp2012

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.